Parametric modeling study of intracellular radionuclide distribution impact in Targeted Alpha Therapy - Archive ouverte HAL
Communication Dans Un Congrès Année : 2023

Parametric modeling study of intracellular radionuclide distribution impact in Targeted Alpha Therapy

Résumé

In the context of predicting biological effects in Targeted Alpha Therapy (TAT), nano/micro-dosimetry are essential to consider the very heterogeneous dose deposition at cell level. The objective of this study is to evaluate theoretically the importance of radionuclide cell internalization in microtumors treated with TAT on physical and biological endpoints. We used Monte Carlo simulations to track alpha particles in complex in silico 3D cell populations using the CPOP/Geant4 code [1], which allows deformable cell membrane to mimic tissue compaction. The code was adapted to generate radionuclide source distributions in various internalization cases that may be encountered in targeted therapy [2] and collect specific energies, alpha kinetic energies and cross-fire contribution in each cell nucleus. The biophysical model NanOx (Nanodosimetry and Oxidative stress) [3] was used to calculate therapeutic indexes from the simulation such as Tumor Control Probability (TCP). We also studied the influence of the cell packing, tumor size, cell line, alpha’s energy and 211At radionuclide daughter diffusion after fixation. When regarding the specific energies, a low impact of radionuclide internalization was found, of less than 5% and 30% in cytoplasm and nucleus source distribution, respectively, compared to membrane adsorption only. The maximum was obtained for small tumors (30 µm radius) because of lower cross-fire contribution. The TCP calculations highlighted larger impact of radionuclide distribution for activity per cell below 30 mBq. For example, a factor up to 18 on TCP was obtained from membrane-to-nucleus distribution in a microtumor of 95µm radius treated with 211At. An RBEµ of 6.9 was calculated in the membrane distribution case. This study highlights the need for considering biological endpoints in the evaluation of intracellular radionuclide distribution impact in TAT response. [1] Maigne, L., et al. Physica Medica 89 (2021): 41-50 [2] Bavelaar, B. M, et al., Frontiers in pharmacology 9 (2018): 996 [3] Cunha, M., et al. Physics in Medicine & Biology 62.4 (2017): 1248
Abstract_EFOMP_2023_RDelorme_RIV-alpha.pdf (516.27 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04305428 , version 1 (24-11-2023)

Identifiants

  • HAL Id : hal-04305428 , version 1

Citer

Victor Levrague, Mario Alcocer-Ávila, Sarah Otmani, Lydia Maigne, Michael Beuve, et al.. Parametric modeling study of intracellular radionuclide distribution impact in Targeted Alpha Therapy. Symposium on Molecular Radiotherapy Dosimetry: The future of theragnostics, EFOMP, Nov 2023, Athènes, Grèce, Greece. ⟨hal-04305428⟩
155 Consultations
24 Téléchargements

Partager

More